Michael Möhr
Impact in
-
- Intensive Care Unit Cognitive Disorders
-
- Algal biology and biofuel production
Papers in
-
- Cardiac Arrest and Resuscitation 13
-
- Respiratory Support and Mechanisms 6
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Paul ChenRoger RuanWenguang ZhouBing HuMin MinH. BurchardiWolfgang E. BerdelL. H. Schmidt
- Journals
- Applied Biochemistry and Biotechnology (4 papers)PLoS ONE (4 papers)Cancers (3 papers)Respiration (3 papers)Bone Marrow Transplantation (3 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Michael Möhr
119 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 158
- Critical Care and Intensive Care Medicine 177
- Renewable Energy, Sustainability and the Environment 450
- Radiological and Ultrasound Technology 102
- Pulmonary and Respiratory Medicine 549
- Oncology 457
Countries citing papers authored by Michael Möhr
This map shows the geographic impact of Michael Möhr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Möhr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Möhr more than expected).
Fields of papers citing papers by Michael Möhr
This network shows the impact of papers produced by Michael Möhr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Möhr. The network helps show where Michael Möhr may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Möhr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 15 | |
| 9 | 2017 | 59 | |
| 10 | 2013 | 44 | |
| 11 | Change in therapy target and therapy limitations in intensive care medicine. Position paper of the Ethics Section of the German Interdisciplinary Association for Intensive Care and Emergency Medicine | 2013 | 20 |
| 12 | Therapiezieländerung und Therapiebegrenzung in der Intensivmedizin: Positionspapier der Sektion Ethik der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin | 2013 | 12 |
| 13 | 2012 | 73 | |
| 14 | 2012 | 89 | |
| 15 | 2007 | 9 | |
| 16 | 2006 | 20 | |
| 17 | 2003 | 83 | |
| 18 | 2001 | 23 | |
| 19 | 1998 | 1 | |
| 20 | 1989 | 15 |
About Michael Möhr
Michael Möhr is a scholar working on Emergency Medicine, Pulmonary and Respiratory Medicine, Hematology, Emergency Medical Services and Critical Care and Intensive Care Medicine, having authored 128 papers that have together received 2.5k indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (14 papers), Cardiac Arrest and Resuscitation (13 papers), Healthcare Decision-Making and Restraints (9 papers), Lung Cancer Research Studies (7 papers), Respiratory Support and Mechanisms (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Peptidase Inhibition and Analysis (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (177 citations), Renewable Energy, Sustainability and the Environment (450 citations), Radiological and Ultrasound Technology (102 citations), Pulmonary and Respiratory Medicine (549 citations) and Oncology (457 citations). Michael Möhr has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Paul Chen, Roger Ruan, Wenguang Zhou, Bing Hu, Min Min, H. Burchardi, Wolfgang E. Berdel, L. H. Schmidt, Georg Evers and Arik Bernard Schulze. Their work appears in journals such as Applied Biochemistry and Biotechnology, PLoS ONE, Cancers, Respiration and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.